Moors & Cabot’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
TWM
TI
APA
ACM
GIA
NA
Moors & Cabot's BTAL Position: Q4 2020 in Review
Moors & Cabot sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2020, closing a stake of 11,000 shares — an estimated $259K sold.
Moors & Cabot first reported a position in BTAL in Q1 2019 and held it in 4 quarters. The position peaked at $411K in Q1 2019. 36 funds tracked by Wall St. Rank hold BTAL as of Q4 2020.
- Moors & Cabot reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2020 after selling out during the quarter.
- Moors & Cabot sold 11,000 AGF US Market Neutral Anti-Beta Fund shares in Q4 2020, an estimated $259K.
- Moors & Cabot first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2019 and held it in 4 quarters.
- Moors & Cabot's AGF US Market Neutral Anti-Beta Fund position peaked at $411K in Q1 2019.
- 36 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2020.
Based on Moors & Cabot's 13F filing for Q4 2020, filed 11 Feb 2021.